These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

289 related items for PubMed ID: 25132747

  • 1. Bowman-Birk inhibitors from legumes as colorectal chemopreventive agents.
    Clemente A, Arques Mdel C.
    World J Gastroenterol; 2014 Aug 14; 20(30):10305-15. PubMed ID: 25132747
    [Abstract] [Full Text] [Related]

  • 2. Bowman-Birk inhibitors from legumes and human gastrointestinal health: current status and perspectives.
    Clemente A, Sonnante G, Domoney C.
    Curr Protein Pept Sci; 2011 Aug 14; 12(5):358-73. PubMed ID: 21418025
    [Abstract] [Full Text] [Related]

  • 3. Biological significance of polymorphism in legume protease inhibitors from the Bowman-Birk family.
    Clementea A, Domoney C.
    Curr Protein Pept Sci; 2006 Jun 14; 7(3):201-16. PubMed ID: 16787260
    [Abstract] [Full Text] [Related]

  • 4. The cytotoxic effect of Bowman-Birk isoinhibitors, IBB1 and IBBD2, from soybean (Glycine max) on HT29 human colorectal cancer cells is related to their intrinsic ability to inhibit serine proteases.
    Clemente A, Moreno FJ, Marín-Manzano Mdel C, Jiménez E, Domoney C.
    Mol Nutr Food Res; 2010 Mar 14; 54(3):396-405. PubMed ID: 19885848
    [Abstract] [Full Text] [Related]

  • 5. The anti-proliferative effect of TI1B, a major Bowman-Birk isoinhibitor from pea (Pisum sativum L.), on HT29 colon cancer cells is mediated through protease inhibition.
    Clemente A, Carmen Marín-Manzano M, Jiménez E, Carmen Arques M, Domoney C.
    Br J Nutr; 2012 Aug 14; 108 Suppl 1():S135-44. PubMed ID: 22916809
    [Abstract] [Full Text] [Related]

  • 6. Role of serine proteases in inflammation: Bowman-Birk protease inhibitor (BBI) as a potential therapy for autoimmune diseases.
    Safavi F, Rostami A.
    Exp Mol Pathol; 2012 Dec 14; 93(3):428-33. PubMed ID: 23022357
    [Abstract] [Full Text] [Related]

  • 7. Development of the Bowman-Birk inhibitor for oral cancer chemoprevention and analysis of Neu immunohistochemical staining intensity with Bowman-Birk inhibitor concentrate treatment.
    Armstrong WB, Wan XS, Kennedy AR, Taylor TH, Meyskens FL.
    Laryngoscope; 2003 Oct 14; 113(10):1687-702. PubMed ID: 14520092
    [Abstract] [Full Text] [Related]

  • 8. Quantitative determination of active Bowman-Birk isoinhibitors, IBB1 and IBBD2, in commercial soymilks.
    Arques MC, Marín-Manzano MC, da Rocha LC, Hernandez-Ledesma B, Recio I, Clemente A.
    Food Chem; 2014 Jul 15; 155():24-30. PubMed ID: 24594149
    [Abstract] [Full Text] [Related]

  • 9. Chemopreventive agents: protease inhibitors.
    Kennedy AR.
    Pharmacol Ther; 1998 Jun 15; 78(3):167-209. PubMed ID: 9690817
    [Abstract] [Full Text] [Related]

  • 10. The Bowman-Birk inhibitor from soybeans as an anticarcinogenic agent.
    Kennedy AR.
    Am J Clin Nutr; 1998 Dec 15; 68(6 Suppl):1406S-1412S. PubMed ID: 9848508
    [Abstract] [Full Text] [Related]

  • 11. Anti-carcinogenic soyabean Bowman-Birk inhibitors survive faecal fermentation in their active form and do not affect the microbiota composition in vitro.
    Marín-Manzano MC, Ruiz R, Jiménez E, Rubio LA, Clemente A.
    Br J Nutr; 2009 Apr 15; 101(7):967-71. PubMed ID: 19353764
    [Abstract] [Full Text] [Related]

  • 12. Proteases, protease inhibitors and radiation carcinogenesis.
    Kennedy AR.
    Int J Radiat Biol; 2023 Apr 15; 99(6):882-890. PubMed ID: 34325613
    [Abstract] [Full Text] [Related]

  • 13. Protease Inhibitors from Plants as Therapeutic Agents- A Review.
    Cid-Gallegos MS, Corzo-Ríos LJ, Jiménez-Martínez C, Sánchez-Chino XM.
    Plant Foods Hum Nutr; 2022 Mar 15; 77(1):20-29. PubMed ID: 35000105
    [Abstract] [Full Text] [Related]

  • 14. Single-dose administration of Bowman-Birk inhibitor concentrate in patients with oral leukoplakia.
    Armstrong WB, Kennedy AR, Wan XS, Atiba J, McLaren CE, Meyskens FL.
    Cancer Epidemiol Biomarkers Prev; 2000 Jan 15; 9(1):43-7. PubMed ID: 10667462
    [Abstract] [Full Text] [Related]

  • 15. Inhibitory properties and solution structure of a potent Bowman-Birk protease inhibitor from lentil (Lens culinaris, L) seeds.
    Ragg EM, Galbusera V, Scarafoni A, Negri A, Tedeschi G, Consonni A, Sessa F, Duranti M.
    FEBS J; 2006 Sep 15; 273(17):4024-39. PubMed ID: 16889634
    [Abstract] [Full Text] [Related]

  • 16. Soybean Bowman-Birk protease inhibitor is a highly effective inhibitor of human mast cell chymase.
    Ware JH, Wan XS, Rubin H, Schechter NM, Kennedy AR.
    Arch Biochem Biophys; 1997 Aug 01; 344(1):133-8. PubMed ID: 9244390
    [Abstract] [Full Text] [Related]

  • 17. Detection of Bowman-Birk inhibitor and anti-Bowman-Birk inhibitor antibodies in sera of humans and animals treated with Bowman-Birk inhibitor concentrate.
    Wan XS, Serota DG, Ware JH, Crowell JA, Kennedy AR.
    Nutr Cancer; 2002 Aug 01; 43(2):167-73. PubMed ID: 12588697
    [Abstract] [Full Text] [Related]

  • 18. Evidence that the Bowman-Birk inhibitor from Pisum sativum affects intestinal proteolytic activities in chickens.
    Moreau T, Recoules E, De Pauw M, Labas V, Réhault-Godbert S.
    Poult Sci; 2024 Jan 01; 103(1):103182. PubMed ID: 37931399
    [Abstract] [Full Text] [Related]

  • 19. Development of Bowman-Birk inhibitor for chemoprevention of oral head and neck cancer.
    Meyskens FL.
    Ann N Y Acad Sci; 2001 Dec 01; 952():116-23. PubMed ID: 11795430
    [Abstract] [Full Text] [Related]

  • 20. The biochemical and functional food properties of the bowman-birk inhibitor.
    Losso JN.
    Crit Rev Food Sci Nutr; 2008 Jan 01; 48(1):94-118. PubMed ID: 18274967
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.